Abstract
In order to receive the most appropriate therapy, patients with Hodgkin's lymphoma (HL) must be accurately stratified into different prognostic staging groups. Computed tomography (CT) plays a pivotal role in the conventional staging. The aim of the present study was to investigate the value of positron emission tomography using 2-[18F]fluoro-2-deoxy-D-glucose (FDG-PET) and combined FDG-PET/CT for the staging of HL patients, and the impact on the choice of treatment.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Haematologica |
Vol/bind | 91 |
Udgave nummer | 4 |
Sider (fra-til) | 482-9 |
Antal sider | 8 |
ISSN | 0390-6078 |
Status | Udgivet - 1 apr. 2006 |